CNSPCNS Pharmaceuticals, Inc.

Nasdaq cnspharma.com


$ 1.18 $ -0.05 (-4.07 %)    

Monday, 15-Jul-2024 10:33:01 EDT
QQQ $ 495.98 $ -0.75 (-0.15 %)
DIA $ 401.87 $ -0.73 (-0.18 %)
SPY $ 561.14 $ -1.04 (-0.18 %)
TLT $ 92.81 $ -0.15 (-0.16 %)
GLD $ 224.13 $ 0.71 (0.32 %)
$ 1.23
$ 1.15
$ 0.00 x 0
$ 1.19 x 100
$ 1.14 - $ 1.18
$ 1.00 - $ 137.50
1,015,346
na
214,332
$ 49.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 12-20-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cns-pharmaceuticals-received-letter-from-nasdaq-notifying-co-that-it-had-regained-compliance-with-bid-price-rule

- SEC Filing

 why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

 cns-pharmaceuticals-stock-was-volatile-wednesday-what-you-need-to-know

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) experienced significant movement in its share price Wednesday afternoon. Here's a ...

 cns-pharmaceuticals-announces-pricing-of-198m-registered-direct-offering-and-concurrent-private-placement-of-1425m-shares-of-common-stock-at-a-combined-purchase-price-of-139-per-share

CNS Pharmaceuticals, Inc.

 cns-pharmaceuticals-announces-pricing-of-registered-direct-offering-and-concurrent-private-placement-of-568k-shares-at-245share

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in t...